(Q81301079)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16200816%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

title

Safety of sublingual-swallow immunotherapy in children aged 3 to 7 years (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16200816%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

1 reference

8

Franco Frati

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16200816%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

author name string

Alessandro Fiocchi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16200816%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Giovanbattista Pajno

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16200816%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Stefania La Grutta

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16200816%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Francesco Pezzuto

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16200816%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Cristoforo Incorvaia

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16200816%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Laura Sensi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16200816%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Francesco Marcucci

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16200816%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

publication date

1 September 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16200816%20AND%20SRC:MED&resulttype=core&format=json

Annals of Allergy, Asthma & Immunology

7 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16200816%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

volume

95

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16200816%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16200816%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

page(s)

254-258

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16200816%20AND%20SRC:MED&resulttype=core&format=json

Systemic reactions to specific immunotherapy in children with respiratory allergy: a prospective study

7 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961222-7

7 January 2021

Local and systemic reactions during immunotherapy with adsorbed extracts of house dust mite in children

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961222-7

7 January 2021

Sublingual immunotherapy for allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961222-7

7 January 2021

Efficacy and safety of sublingual immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961222-7

7 January 2021

Post-marketing surveillance study on the safety of sublingual immunotherapy in pediatric patients

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961222-7

7 January 2021

Long-lasting effect of sublingual immunotherapy in children with asthma due to house dust mite: a 10-year prospective study.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961222-7

7 January 2021

Clinical and immunologic effects of long-term sublingual immunotherapy in asthmatic children sensitized to mites: a double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961222-7

7 January 2021

Immunomodulation during sublingual therapy in allergic children

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961222-7

7 January 2021

Sublingual tryptase and ECP in children treated with grass pollen sublingual immunotherapy (SLIT): safety and immunologic implications.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961222-7

7 January 2021

House-dust-mite sublingual-swallow immunotherapy (SLIT) in perennial rhinitis: a double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961222-7

7 January 2021

House-dust mite sublingual-swallow immunotherapy in perennial conjunctivitis: a double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961222-7

7 January 2021

Allergic rhinitis due to house dust mites: evaluation of the efficacy of specific sublingual immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961222-7

7 January 2021

Immunotherapy safety: a prospective multi-centric monitoring study of biologically standardized therapeutic vaccines for allergic diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961222-7

7 January 2021

Canadian trial of sublingual swallow immunotherapy for ragweed rhinoconjunctivitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961222-7

7 January 2021

A prospective, randomized, double-blind, placebo-controlled multi-centre study on the efficacy and safety of sublingual immunotherapy (SLIT) in children with seasonal allergic rhinoconjunctivitis to grass pollen.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961222-7

7 January 2021

Position paper: Immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961222-7

7 January 2021

The appropriate use of skin testing and allergen immunotherapy in young children

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961222-7

7 January 2021

Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961222-7

7 January 2021

Allergic rhinitis and its impact on asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961222-7

7 January 2021

Appropriate and inappropriate use of immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961222-7

7 January 2021

Minimization: A new method of assigning patients to treatment and control groups

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961222-7

7 January 2021

The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961222-7

7 January 2021

Allergy testing in children: why, who, when and how?

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961222-7

7 January 2021

Differential diagnosis of IgE-mediated allergy in young children with wheezing or eczema symptoms using a single blood test

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961222-7

7 January 2021

Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961222-7

7 January 2021

Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study).

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961222-7

7 January 2021

Survey of fatalities from skin testing and immunotherapy 1985-1989.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961222-7

7 January 2021

10.1016/S1081-1206(10)61222-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16200816%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

1 reference